When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
A research team from Brazil evaluated the link between anxiety and depression — nonmotor symptoms of Parkinson’s disease (PD) — and freezing of gait. They found that roughly…
Interim results from the preliminary analysis of the JAVELIN-Renal 101 trial suggest that adding immunotherapy to a targeted agent appears to significantly improve progression-free survival (PFS) when compared with a…
Vanderbilt neurosurgeons fit DBS electrodes with extraordinary precision on patients to treat Parkinson’s disease tremors that cannot be treated with medications.
Chronic severe pain affects one in five Americans. Complex regional pain syndrome, a subtype of chronic severe pain, is a severe pain disorder that develops following minor surgery…
At Boston University School of Medicine, a research team led by Lee Goldstein, MD, PhD, identified the mechanism of chronic traumatic encephalopathy (CTE). This neurodegenerative disease is associated…
An innovative device developed by Klick Labs can recreate parkinsonian tremor in healthy individuals. Designed to increase empathy among caregivers, SymPulse Tele-Empathy Device records a patient’s hand tremors…
Physician experts observe that patients with Parkinson’s disease don’t always eat enough to meet their energy needs, which are typically higher than those of non-Parkinson’s patients.
